StonvexLoading…
StonvexStonvexStonvexCore line items from COHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.07B | $3.27B | $1.58B | $5.81B |
Operating Income | $569.22M | $384.87M | $216.89M | $94.18M |
Net Income | $564.47M | $373.07M | $226.35M | $49.36M |
EPS (Diluted) | $2.92 | $1.95 | $1.19 | $-0.52 |
Total Assets | $17.29B | $15.09B | $14.70B | $14.91B |
Total Liabilities | $6.27B | $6.20B | $6.01B | $6.43B |
Cash & Equivalents | $1.59B | $863.74M | $852.78M | $909.20M |
Free Cash Flow OCF − CapEx | $-537.17M | $-153.69M | $-57.99M | $192.76M |
Shares Outstanding | 193.13M | 191.72M | 190.68M | 154.75M |